Deprescribing is the planned process of tapering or stopping medications that may no longer be needed, with the goal of reducing harm and improving quality of life. It’s most common among older adults who take five or more daily medications, a situation known as polypharmacy that affects nearly 40% of the elderly population worldwide. Deprescribing isn’t about cutting corners on care. It’s a structured, supervised approach to making sure every pill you take is still doing more good than harm.
Why Deprescribing Matters
Medications that made sense five years ago may not make sense today. Health conditions change, body chemistry shifts with age, and drugs can interact with each other in ways that create new problems. A blood pressure medication prescribed at 60 might cause dangerous dizziness at 80. A sleeping pill started during a stressful period might still be refilled a decade later out of habit. Deprescribing asks a simple question about each medication: is this still helping more than it’s hurting?
The scale of the problem is significant. A meta-analysis covering more than 57 million people found that 39.1% of older adults worldwide take five or more medications daily. In Europe and North America, that figure climbs to roughly 45%. People aged 70 and older and those living in nursing homes face even higher rates. Each additional medication increases the risk of side effects, drug interactions, falls, confusion, and hospitalization. Deprescribing is one of the primary tools for managing this burden.
Which Medications Are Commonly Targeted
Not every drug is a candidate for deprescribing. Clinicians typically focus on medication classes known to carry higher risks for older adults. The most frequently evaluated include:
- Benzodiazepines and similar sleep aids: Often prescribed for anxiety or insomnia, these carry significant risks of falls, cognitive impairment, and physical dependence. Research consistently finds that an overwhelming number of long-term users are candidates for deprescribing, primarily due to inappropriately long use and accumulating side effects.
- Proton pump inhibitors (PPIs): Acid-reducing medications often started for heartburn or ulcers and continued indefinitely. Long-term use is linked to bone fractures, kidney problems, and nutrient deficiencies.
- Opioid pain medications: Chronic use can lead to tolerance, dependence, and increased sensitivity to pain over time.
- Anti-inflammatory pain relievers (NSAIDs): Regular use raises the risk of stomach bleeding, kidney damage, and cardiovascular events, particularly in older adults.
- Blood pressure medications: A trial published in The Lancet Healthy Longevity found that more than half of older adults who attempted blood pressure medication reduction were able to sustain it for four years with no evidence of harm.
Screening tools like the American Geriatrics Society’s Beers Criteria, most recently updated in 2023, help clinicians identify medications that are potentially inappropriate for older adults. These tools flag drugs with unfavorable risk-to-benefit ratios based on age, kidney function, and other health conditions.
How the Process Works
Deprescribing follows a structured approach, not a sudden stop. The general process involves several key steps.
First, your healthcare provider reviews your full medication list and asks what matters most to you. This might mean prioritizing independence, reducing side effects, simplifying your daily routine, or managing a specific symptom. Your goals shape which medications get evaluated first. For someone with early-stage memory problems, for example, eliminating drugs that cause drowsiness or confusion might be the top priority.
Next comes a careful weighing of each medication’s risks and benefits in light of your current health. A cholesterol-lowering drug might offer meaningful protection for a 65-year-old but provide minimal benefit for someone in their late 80s with a limited life expectancy. The provider considers how long you’ve been on the drug, whether the original reason for prescribing it still applies, and whether the medication could be causing symptoms you’re currently experiencing.
Then comes the tapering plan. Some medications can be stopped immediately without problems. Cholesterol-lowering statins, for instance, can typically be discontinued outright. Others require a slow, gradual reduction to avoid withdrawal symptoms or a rebound of the original condition. A common starting approach is reducing the dose by 25 to 50% every two to four weeks, with regular check-ins throughout.
Tapering Timelines by Drug Type
The speed and approach to tapering varies considerably depending on the medication. Benzodiazepines, for example, should never be stopped abruptly because they cause both psychological and physical dependence. One widely used approach reduces the dose to 50% over the first two to four weeks, holds steady for one to two months, then reduces by 25% every two weeks after that. A typical full taper takes about three months, though some people need longer.
Opioid tapering timelines depend on how long you’ve been taking the medication. For people who have used opioids for a year or more, guidelines from the CDC recommend reducing the dose by no more than 10% per month. For shorter durations of use, a 10% reduction per week is typical until the dose reaches about 30% of the starting amount, at which point the pace slows. The VA recommends a 5 to 20% reduction every four weeks or longer, emphasizing that the schedule should be individualized.
Acid-reducing medications like PPIs are sometimes tapered even when they could technically be stopped outright. A gradual step-down reduces the chance of rebound acid production, which can temporarily worsen heartburn and make people think they still need the drug. It also builds confidence that stopping is safe.
What Monitoring Looks Like
Deprescribing doesn’t end when the last pill is skipped. Monitoring afterward is essential for two reasons: catching the return of original symptoms and distinguishing those symptoms from withdrawal effects. This distinction matters more than most people realize. If you feel anxious two weeks after tapering an anxiety medication, it could be withdrawal (temporary and expected) or a genuine return of anxiety (which might need a different treatment approach). Without proper follow-up, it’s easy to mistake one for the other and restart a medication unnecessarily.
Your provider will typically schedule more frequent check-ins during and after a taper. These visits focus on how you’re feeling physically and emotionally, whether any symptoms have returned, and whether the reduction is happening at a comfortable pace. You’ll usually be asked to watch for specific warning signs and to have a plan in place if things feel off, whether that means calling your doctor, leaning on a family member, or adjusting the timeline. For certain medications, providers also watch for concerning patterns like turning to alcohol or over-the-counter drugs to replace the effects of the discontinued medication.
Common Fears and Barriers
Even when the medical rationale is strong, stopping a long-term medication can feel unsettling. Research from the Shed-MEDS clinical trial identified three categories of barriers that patients commonly report.
Fear is the most prominent. People worry that stopping a medication will cause their original condition to come back, trigger dangerous withdrawal symptoms, or lead to a health crisis. This is especially true for medications they’ve taken for years. There’s an understandable logic to it: the medication has been part of their routine for so long that it feels like a load-bearing wall you shouldn’t remove.
Process frustration is another barrier. Deprescribing can feel complicated, requiring multiple appointments, slow dose changes, and ongoing monitoring. Some people feel the timing isn’t right or that the effort isn’t worth it when things seem to be going fine.
Pragmatic resistance rounds out the list. Long-term use itself becomes a reason to keep going. People assume that if a drug hasn’t caused obvious problems yet, it must be safe. There’s also a tendency to view medication as inherently safer than not taking medication, even when the evidence points the other way.
Shared Decision-Making
Deprescribing works best as a conversation, not a directive. The most effective approach involves what clinicians call shared decision-making, where you and your provider discuss options together rather than having changes handed down as instructions. One widely used framework breaks this into three stages: a team talk (agreeing to work together on the decision), an option talk (reviewing the specific risks and benefits of continuing versus stopping), and a decision talk (choosing a path forward that reflects your priorities).
Communication research suggests a few practices that make these conversations more productive. Using plain, everyday language rather than medical jargon helps you actually weigh the information. Presenting risks as absolute numbers (“3 out of 100 people experience this”) rather than relative comparisons (“50% more likely”) gives a more accurate picture. Visual aids like simple charts showing how many people are helped versus harmed by a medication can make abstract statistics concrete.
If your provider hasn’t brought up deprescribing, you can start the conversation yourself. Asking “Do I still need all of these medications?” or “Could any of my symptoms be side effects?” are straightforward ways to open the door. Pharmacists, who often have the clearest view of your full medication list, can also be valuable partners in identifying candidates for review.